AI Detection of Incidental Coronary Artery Calcium to Enhance Cardiovascular Disease Prevention

Launched by BRIGHAM AND WOMEN'S HOSPITAL · Jan 23, 2024

Keywords

ClinConnect Summary

The AI INFORM study is a clinical trial that is exploring how using advanced technology can help doctors better prevent heart disease. The trial focuses on detecting calcium build-up in the coronary arteries, which can be a sign of heart disease. By analyzing chest CT scans with a special artificial intelligence (AI) tool, researchers hope to see if giving doctors information about this calcium can lead to starting or increasing treatments that help keep patients' hearts healthy.

To be eligible for this study, participants should be between the ages of 40 and 75 and should have had a chest CT scan in the last three years. However, individuals with a history of heart disease, cancer, or other serious health conditions may not be able to participate. Those who join the study can expect to contribute to important research that could improve heart disease prevention for many people. It’s an exciting opportunity to be part of a trial that uses cutting-edge technology to potentially make a real difference in heart health.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients aged between 40-75 with prior chest CT within last 3 years
• Exclusion Criteria:
• • Prior coronary artery disease
• • Prior cancer
• • Other life-limiting condition